STOCK TITAN
  1. Home
  2. Sec-filings
  3. SOPH
  4. [Form 4] SOPHiA GENETICS SA Insider Trading Activity

SOPHiA GENETICS (SOPH) CTO’s 5,285-share sale covers RSU tax via 10b5-1 plan

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

SOPHiA GENETICS SA Chief Technology Officer Abhimanyu Verma reported a sale of 5,285 Ordinary Shares in an open-market transaction. The weighted average sale price was about $5.10 per share, with individual trades between $4.97 and $5.41.

According to the footnotes, these shares were sold to satisfy tax withholding obligations tied to restricted stock units that vested on July 2 and July 3, 2026. The transactions were executed under a pre-established Rule 10b5-1(c) trading plan and are described as non-discretionary. After the sale, Verma directly holds 192,171 Ordinary Shares.

Positive

  • None.

Negative

  • None.
Insider Verma Abhimanyu
Role Chief Technology Officer
Sold 5,285 shs ($27K)
Type Security Shares Price Value
Sale Ordinary Shares 5,285 $5.1007 $27K
Holdings After Transaction: Ordinary Shares — 192,171 shares (Direct, null)
Footnotes (1)
  1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on July 2 and July 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.97 to $5.41, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares sold 5,285 shares Open-market sale on July 6, 2026
Weighted average sale price $5.1007 per share Ordinary Shares sold by CTO
Sale price range $4.97–$5.41 per share Multiple executions within this range
Shares held after transaction 192,171 shares Direct ownership following sale
RSU vesting dates July 2 and July 3, 2026 Tax obligations triggering the sale
Rule 10b5-1(c) trading plan regulatory
"These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person"
A Rule 10b5-1(c) trading plan is a legally defined, pre-set schedule that lets company insiders automatically buy or sell stock at specified times or under set formulas when they are not in possession of undisclosed, sensitive information. Think of it like an automatic payment plan for trades: because the instructions are written in advance, trades under the plan help protect insiders from allegations of trading on secret information and give investors clearer expectations about when insiders will transact, which can affect liquidity and perceived transparency.
restricted stock units financial
"tax withholding obligations arising in connection with the vesting of restricted stock units on July 2 and July 3, 2026"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting"
weighted average price financial
"The price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did SOPHiA GENETICS (SOPH) report for Abhimanyu Verma?
SOPHiA GENETICS reported that CTO Abhimanyu Verma sold 5,285 Ordinary Shares. The sale was an open-market transaction primarily to cover tax withholding on recently vested restricted stock units, rather than a discretionary portfolio decision.

At what price did Abhimanyu Verma sell SOPHiA GENETICS (SOPH) shares?
The filing shows a weighted average sale price of $5.1007 per share. Footnotes explain the shares were sold in multiple trades at prices ranging from $4.97 to $5.41, with detailed breakdowns available on request from the company or regulators.

Why did SOPHiA GENETICS CTO Abhimanyu Verma sell 5,285 shares?
The shares were sold to satisfy tax withholding obligations from restricted stock units that vested on July 2 and July 3, 2026. This type of sale is a common administrative step when equity awards vest and does not reflect a discretionary trading decision.

Was the SOPHiA GENETICS (SOPH) insider sale made under a Rule 10b5-1 plan?
Yes. The filing states the sales were executed under a pre-established Rule 10b5-1(c) trading plan. Such plans schedule trades in advance, which reduces the significance of the exact timing as an indicator of the insider’s current view on the stock.

How many SOPHiA GENETICS shares does Abhimanyu Verma hold after this sale?
After the reported sale, Abhimanyu Verma directly holds 192,171 Ordinary Shares. This context shows that the 5,285 shares sold for tax withholding represent a relatively small portion of his overall reported equity position in the company.

What does the price range in Abhimanyu Verma’s SOPHiA GENETICS sale mean?
The filing notes that the reported price is a weighted average, with individual trades between $4.97 and $5.41. This indicates multiple executions across that range, and the insider has committed to provide detailed per-trade information upon written request.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Verma Abhimanyu
(Last)(First)(Middle)
C/O SOPHIA GENETICS SA
LA PIECE 12
(Street)
ROLLE1180
(City)(State)(Zip)
SWITZERLAND
(Country)		2. Issuer Name and Ticker or Trading Symbol
SOPHiA GENETICS SA [ SOPH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Technology Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/06/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares07/06/2026S5,285(1)D$5.1007(2)192,171D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on July 2 and July 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.97 to $5.41, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks:
/s/ Elimara Brunetto as Attorney-in-fact for Abhimanyu Verma07/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR